Philip Morris to Launch IQOS ILUMA NEON PURPLE in Spain

Jun.11.2024
Philip Morris to Launch IQOS ILUMA NEON PURPLE in Spain
Philip Morris International (PMI) to launch limited edition IQOS ILUMA NEON PURPLE in Spanish cities with innovative digital campaign.

According to a recent report by Ipmark, Philip Morris International (PMI) will launch a limited edition new product called IQOS ILUMA NEON PURPLE in several cities in Spain this summer.


The company plans to conduct a summer digital advertising campaign (Fake Out Of Home) in the cities of Madrid, Barcelona, and Valencia. They will decorate a limited edition blimp in neon colors and have it fly in the skies of Madrid, Barcelona, and Valencia. The blimp will also interact with the cities and use neon lights to illuminate three stores of the brand located in those three locations during its flight.


Alejandro Flores, marketing manager for IQOS in the Spanish market, stated that...


IQOS has changed the game by offering a product that heats tobacco instead of burning it, creating a better alternative to smoking. Innovation, disruption, and finding better ways of doing things have always been the brand's DNA. These values are not only reflected in the product itself but also in their communication strategies, which is why they are launching the "Fake Out Of Home" campaign to showcase their latest product: IQOS ILUMA NEON PURPLE.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT appoints Matthew Wright as Independent Non-Executive Director, effective November 1, 2025
BAT appoints Matthew Wright as Independent Non-Executive Director, effective November 1, 2025
Matthew Wright appointed as independent non-executive director of British American Tobacco, effective November 1, bringing extensive international executive experience.
Oct.15 by 2FIRSTS.ai
Product | ELFBAR Launches New Open-System Device in UK with Three Pod Options and 2800mAh Battery
Product | ELFBAR Launches New Open-System Device in UK with Three Pod Options and 2800mAh Battery
ELFBAR has launched its new open-system device ELFX MEGA, compatible with 2 mL, 5 mL and 10 mL pods and equipped with a 2800mAh battery that delivers significantly longer runtime than its predecessor. The device has passed MHRA notification in the UK and is now available online in the UK at a retail price of around £18.99.
Nov.25 by 2FIRSTS.ai
UK Government Officially Confirms Vaping Products Duty and Stamps Scheme, Effective October 2026
UK Government Officially Confirms Vaping Products Duty and Stamps Scheme, Effective October 2026
HM Revenue & Customs (HMRC) has officially confirmed that the UK will implement a Vaping Products Duty (VPD) and Vaping Duty Stamps (VDS) scheme from October 1, 2026. The duty will apply to all vaping liquids at a flat rate of £2.20 per 10ml. Businesses must register for approval starting April 1, 2026. The stamps scheme will take effect in October 2026 with a six-month grace period, after which, from April 2027, unstamped products will be prohibited from sale.
Oct.02 by 2FIRSTS.ai
Feature | Vape Politics in Russia: Local Governments Push Forward Despite Legislative Deadlock
Feature | Vape Politics in Russia: Local Governments Push Forward Despite Legislative Deadlock
As Russia’s federal vape policy stalls, regional governors are racing to implement local bans—now with the backing of President Vladimir Putin. The divide between swift local action and delayed national legislation is fueling debate over health, regulation, and the country’s broader approach to nicotine control.
Oct.28
 Australia NSW Police Crack Down on Illicit Tobacco Syndicate Under Strike Force Franklin
Australia NSW Police Crack Down on Illicit Tobacco Syndicate Under Strike Force Franklin
NSW Police, together with NSW Health and the Australian Border Force, seized more than 18,000 vapes, 1.9 million cigarettes, 74kg of loose-leaf tobacco and five unregistered firearms during a week of action under Strike Force Franklin. Four people were charged following coordinated raids on the Far North Coast. Police said the operation targeted organised crime networks profiting from illicit tobacco sales, with an estimated street value exceeding $2.35 million(1.54 million US dollars)..
Nov.03 by 2FIRSTS.ai
ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21